Počet záznamů: 1
Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress
- 1.0369512 - BTÚ 2012 RIV NL eng J - Článek v odborném periodiku
Ito, K. - Scott, S.A. - Cutler, S. - Dong, L.-F. - Neužil, Jiří - Blanchard, H. - Ralph, S.J.
Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress.
Angiogenesis. Roč. 14, č. 3 (2011), s. 293-307. ISSN 0969-6970. E-ISSN 1573-7209
Výzkumný záměr: CEZ:AV0Z50520701
Klíčová slova: Galectin-1 inhibitor * oxidative stress * angiogenesis
Kód oboru RIV: FD - Onkologie a hematologie
Impakt faktor: 6.063, rok: 2011
Trvalý link: http://hdl.handle.net/11104/0203559
Počet záznamů: 1